Trial Profile
Physiological Iron Maintenance in End Stage Renal Disease (ESRD) Subjects by Delivery of Soluble Ferric Pyrophosphate (SFP) Via Hemodialysate: The PRIME Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Ferric pyrophosphate (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Acronyms PRIME
- Sponsors Rockwell Medical Technologies
- 28 Jun 2017 According to a Rockwell Medical India media release, data from the study will be presented in an oral presentation at the 12th Annual Conference on Nephrology & Urology 2017.
- 13 Jul 2015 Results published in a Rockwell Medical Technologies media release.
- 13 Jul 2015 Results published in Kidney International, according to a Rockwell Medical Technologies media release.